Conatus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
CNAT Conatus Pharmaceuticals Inc
PEP PepsiCo Inc
PVTL Pivotal Software Inc
AIPT Precision Therapeutics Inc
SPN Superior Energy Services Inc
NOV National Oilwell Varco Inc
SCS Steelcase Inc
PRTK Paratek Pharmaceuticals Inc
ASPU Aspen Group Inc
AFBA Allied First Bancorp Inc
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease. Emricasan has the potential to interrupt the progression of liver disease and provide treatment options in multiple areas of liver disease. Emricasan is designed to slow or halt the progression of chronic liver disease caused by fibrosis and cirrhosis. Emricasan works by inhibiting caspases, which are a family of related enzymes that plays as modulators of critical cellular functions, including functions that result in apoptosis and inflammation.

Price
Delayed
$1.68
Day's Change
0.175 (11.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.68
Day's Low
1.53
Volume
(Average)

Today's volume of 545,193 shares is on pace to be in-line with CNAT's 10-day average volume of 1,819,443 shares.

545,193
  • Prev Close
    1.50
  • Today's Open
    1.55
  • Day's Range
    1.53-1.68
  • Avg Vol (10-day)
    1.8M
  • Last (time)
    11:03a ET 12/11/18
  • Last (size)
    100
  • 52-Wk Range
    1.49 - 7.95
    LowHigh
  • (03/09/18 - 12/10/18)
    12.42%
  • 119.0%
  • Market Cap
    50.7M
  • Shares Outstanding
    30.3M
  • -0.61
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.6
  • 30.73
  • (% of float 11/15/18)
    11.39

Latest News

December 06, 2018
2:13 pm ET
MarketWatch
1:33 pm ET
MarketWatch
7:39 am ET
MarketWatch
7:39 am ET
MarketWatch
December 05, 2018
7:30 am ET
Globe Newswire
November 16, 2018
7:50 am ET
Globe Newswire
November 08, 2018
7:30 am ET
Globe Newswire
November 01, 2018
4:07 pm ET
Globe Newswire
October 25, 2018
7:30 am ET
Globe Newswire
October 02, 2018
4:05 pm ET
Globe Newswire
September 20, 2018
7:30 am ET
Globe Newswire
7:13 am ET
BusinessWire
September 19, 2018
7:30 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.